Skip to main content
MNOV logo
MNOV
(NASDAQ)
MediciNova, Inc.
$1.44-- (--)
Loading... - Market loading

MediciNova (MNOV) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

MediciNova Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
MediciNova, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue0.410.001.000.004.040.000.000.000.00
Cost of Revenue0.380.000.000.000.000.000.020.030.03
Gross Profit0.030.001.000.004.040.00-0.02-0.03-0.03
Operating Expenses
Research & Development7.157.195.669.148.547.496.085.634.22
Selling, General & Administrative6.165.485.245.485.726.697.959.968.80
Operating Expenses13.3112.6810.9014.6314.2514.1814.0315.5913.03
Operating Income-13.28-12.68-9.90-14.63-10.22-14.18-14.03-15.59-13.03
Other Income/Expense
Interest Income1.301.671.830.810.140.361.150.940.00
Interest Expense0.000.000.000.000.000.000.000.000.00
Other Income/Expense-0.01-0.04-0.50-0.25-0.060.321.100.920.12
Income
Income Before Tax-11.99-11.04-8.57-14.07-10.13-13.86-12.93-14.67-12.91
Income Tax Expense0.010.010.000.000.000.000.010.01-1.74
Net Income-12.00-11.05-8.57-14.07-10.13-13.85-12.94-14.68-11.16
Net Income - Continuous Operations-12.00-11.05-8.57-14.07-10.13-13.85-12.94-14.68-11.16
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.000.00
EBITDA-13.26-12.65-9.88-14.61-10.19-14.16-14.01-15.56-13.00
EBIT-13.28-12.68-9.90-14.63-10.22-14.180.000.000.00
Depreciation & Amortization0.020.020.020.020.030.020.020.030.03
Earnings Per Share
Basic EPS---------
Diluted EPS---------
Basic Shares Outstanding49.0649.0549.0549.0548.6044.4143.1641.1235.14
Diluted Shares Outstanding49.0649.0549.0549.0548.6044.4143.1641.1235.14

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.